Literature DB >> 24771548

UBQLN2 mutation causing heterogeneous X-linked dominant neurodegeneration.

Donald H Harter1, Christine E Seidman2,3, Akl C Fahed2, Barbara McDonough2,3, Cynthia M Gouvion4, Kathy L Newell4, Leon S Dure5, Martina Bebin5, Alexander G Bick2, J G Seidman2.   

Abstract

We report a 5-generation family with phenotypically diverse neurodegenerative disease including relentlessly progressive choreoathetoid movements, dysarthria, dysphagia, spastic paralysis, and behavioral dementia in descendants of a 67-year-old woman with amyotrophic lateral sclerosis. Disease onset varied with gender, occurring in male children and adult women. Exome sequence analyses revealed a novel mutation (c.1490C>T, p.P497L) in the ubiquilin-2 gene (UBQLN2) with X-linked inheritance in all studied affected individuals. As ubiquilin-2-positive inclusions were identified in brain, we suggest that mutant peptide predisposes to protein misfolding and accumulation. Our findings expand the spectrum of neurodegenerative phenotypes caused by UBQLN2 mutations.
© 2014 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24771548      PMCID: PMC4106259          DOI: 10.1002/ana.24164

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

1.  Mutations in UBQLN2 are rare in French amyotrophic lateral sclerosis.

Authors:  Stéphanie Millecamps; Philippe Corcia; Cécile Cazeneuve; Séverine Boillée; Danielle Seilhean; Véronique Danel-Brunaud; Nadia Vandenberghe; Pierre-François Pradat; Nadine Le Forestier; Lucette Lacomblez; Gaëlle Bruneteau; William Camu; Alexis Brice; Vincent Meininger; Eric LeGuern; François Salachas
Journal:  Neurobiol Aging       Date:  2011-12-09       Impact factor: 4.673

2.  Screening in ALS and FTD patients reveals 3 novel UBQLN2 mutations outside the PXX domain and a pure FTD phenotype.

Authors:  Matthis Synofzik; Walter Maetzler; Torsten Grehl; Johannes Prudlo; Jennifer Müller Vom Hagen; Tobias Haack; Piret Rebassoo; Marita Munz; Ludger Schöls; Saskia Biskup
Journal:  Neurobiol Aging       Date:  2012-08-11       Impact factor: 4.673

3.  UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis.

Authors:  Kelly L Williams; Sadaf T Warraich; Shu Yang; Jennifer A Solski; Ruvini Fernando; Guy A Rouleau; Garth A Nicholson; Ian P Blair
Journal:  Neurobiol Aging       Date:  2012-06-19       Impact factor: 4.673

4.  UBQLN2 in familial amyotrophic lateral sclerosis in The Netherlands.

Authors:  Perry T C van Doormaal; Wouter van Rheenen; Marka van Blitterswijk; Raymond D Schellevis; Helenius J Schelhaas; Marianne de Visser; Anneke J van der Kooi; Jan H Veldink; Leonard H van den Berg
Journal:  Neurobiol Aging       Date:  2012-06-05       Impact factor: 4.673

5.  Explorative genetic study of UBQLN2 and PFN1 in an extended Flanders-Belgian cohort of frontotemporal lobar degeneration patients.

Authors:  Lubina Dillen; Tim Van Langenhove; Sebastiaan Engelborghs; Mathieu Vandenbulcke; Stayko Sarafov; Ivailo Tournev; Celine Merlin; Patrick Cras; Rik Vandenberghe; Peter P De Deyn; Albena Jordanova; Marc Cruts; Christine Van Broeckhoven; Julie van der Zee
Journal:  Neurobiol Aging       Date:  2013-01-09       Impact factor: 4.673

6.  Adult Hallervorden-Spatz syndrome simulating amyotrophic lateral sclerosis.

Authors:  O M Vasconcelos; D H Harter; C Duffy; B McDonough; J G Seidman; C E Seidman; W W Campbell
Journal:  Muscle Nerve       Date:  2003-07       Impact factor: 3.217

7.  UBQLN2 mutations are rare in French and French-Canadian amyotrophic lateral sclerosis.

Authors:  Hussein Daoud; Hamid Suhail; Anna Szuto; William Camu; Francois Salachas; Vincent Meininger; Jean-Pierre Bouchard; Nicolas Dupré; Patrick A Dion; Guy A Rouleau
Journal:  Neurobiol Aging       Date:  2012-05-03       Impact factor: 4.673

8.  Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Cinzia Gellera; Cinzia Tiloca; Roberto Del Bo; Lucia Corrado; Viviana Pensato; Jennifer Agostini; Cristina Cereda; Antonia Ratti; Barbara Castellotti; Stefania Corti; Alessandra Bagarotti; Annachiara Cagnin; Pamela Milani; Carlo Gabelli; Giulietta Riboldi; Letizia Mazzini; Gianni Sorarù; Sandra D'Alfonso; Franco Taroni; Giacomo Pietro Comi; Nicola Ticozzi; Vincenzo Silani
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-11-08       Impact factor: 10.154

9.  Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia.

Authors:  Han-Xiang Deng; Wenjie Chen; Seong-Tshool Hong; Kym M Boycott; George H Gorrie; Nailah Siddique; Yi Yang; Faisal Fecto; Yong Shi; Hong Zhai; Hujun Jiang; Makito Hirano; Evadnie Rampersaud; Gerard H Jansen; Sandra Donkervoort; Eileen H Bigio; Benjamin R Brooks; Kaouther Ajroud; Robert L Sufit; Jonathan L Haines; Enrico Mugnaini; Margaret A Pericak-Vance; Teepu Siddique
Journal:  Nature       Date:  2011-08-21       Impact factor: 49.962

  9 in total
  24 in total

1.  The specificity of ubiquitin binding to ubiquilin-1 is regulated by sequences besides its UBA domain.

Authors:  Christine A Harman; Mervyn J Monteiro
Journal:  Biochim Biophys Acta Gen Subj       Date:  2019-06-06       Impact factor: 3.770

2.  Wildtype sigma-1 receptor and the receptor agonist improve ALS-associated mutation-induced insolubility and toxicity.

Authors:  Yasuharu Shinoda; Yudai Haga; Koichiro Akagawa; Kohji Fukunaga
Journal:  J Biol Chem       Date:  2020-10-14       Impact factor: 5.157

3.  Ubiquilin-2 differentially regulates polyglutamine disease proteins.

Authors:  Julia E Gerson; Nathaniel Safren; Svetlana Fischer; Ronak Patel; Emily V Crowley; Jacqueline P Welday; Alexandra K Windle; Sami Barmada; Henry L Paulson; Lisa M Sharkey
Journal:  Hum Mol Genet       Date:  2020-08-29       Impact factor: 6.150

Review 4.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

5.  Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations.

Authors:  Nhat T T Le; Lydia Chang; Irina Kovlyagina; Polymnia Georgiou; Nathaniel Safren; Kerstin E Braunstein; Mark D Kvarta; Adam M Van Dyke; Tara A LeGates; Thomas Philips; Brett M Morrison; Scott M Thompson; Adam C Puche; Todd D Gould; Jeffrey D Rothstein; Philip C Wong; Mervyn J Monteiro
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-09       Impact factor: 11.205

6.  ALS-Linked Mutations Affect UBQLN2 Oligomerization and Phase Separation in a Position- and Amino Acid-Dependent Manner.

Authors:  Thuy P Dao; Brian Martyniak; Ashley J Canning; Yongna Lei; Erica G Colicino; Michael S Cosgrove; Heidi Hehnly; Carlos A Castañeda
Journal:  Structure       Date:  2019-04-11       Impact factor: 5.006

7.  Signature changes in ubiquilin expression in the R6/2 mouse model of Huntington's disease.

Authors:  Nathaniel Safren; Lydia Chang; Kristina M Dziki; Mervyn J Monteiro
Journal:  Brain Res       Date:  2014-12-12       Impact factor: 3.252

8.  Disrupting the Balance of Protein Quality Control Protein UBQLN2 Accelerates Tau Proteinopathy.

Authors:  Julia E Gerson; Stephanie Sandoval-Pistorius; Jacqueline P Welday; Aleija Rodriguez; Jordan D Gregory; Nyjerus Liggans; Kylie Schache; Xingli Li; Hanna Trzeciakiewicz; Sami Barmada; Lisa M Sharkey; Henry L Paulson
Journal:  J Neurosci       Date:  2022-01-26       Impact factor: 6.709

Review 9.  Structure, dynamics and functions of UBQLNs: at the crossroads of protein quality control machinery.

Authors:  Tongyin Zheng; Yiran Yang; Carlos A Castañeda
Journal:  Biochem J       Date:  2020-09-30       Impact factor: 3.857

10.  Wildtype σ1 receptor and the receptor agonist improve ALS-associated mutation-induced insolubility and toxicity.

Authors:  Yasuharu Shinoda; Yudai Haga; Koichiro Akagawa; Kohji Fukunaga
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.